Corteva Reportedly Plans Pesticides Spinoff, Shares Fall 5%

Corteva Reportedly Planning Pesticides Spinoff — Undoing DowDuPont’s “Most Complicated Action”

The “most complicated action in corporate history” may be on the verge of getting still more complicated. Back in 2019, DowDuPont completed the spinoff of Corteva(CTVA). That deal was the culmination of a frenetic few years of corporate machinations. Dow and DuPont merged, shuffled businesses around, then split into three companies. Corteva emerged as the agriculture pure play, combining Dow’s seed business with DuPont’s pesticides business.

At the time, Sanford Bernstein analyst Jonas Oxgaard memorably dubbed it “the most complicated action in corporate history.” He may have to update his notes.


Seeds vs. Pesticides: The Numbers

According to The Wall Street Journal, Corteva is now considering separating its seed and pesticide units into two public companies. That would mean undoing the very combination that defined its creation.

  • Seeds: $9.6 billion in revenue last year

  • Pesticides (Crop Protection): $7.4 billion in revenue

Both are substantial businesses in their own right, and the spin would create two large industrial players — one focused on crop genetics, the other on chemical protection.


Liability Lessons: From Chemours to Corteva

One driver for the move may be legal risk. Splitting seed and pesticide operations could help shield the seed business from pesticide liability. That’s a playbook Corteva knows all too well from its corporate ancestors.

In 2015, DuPont spun off Chemours in part to isolate PFAS (“forever chemicals”) liability. It didn’t work. Chemours, DuPont, and Corteva have all ended up on the hook, paying hundreds of millions of dollars in settlements. That precedent looms large — and it’s easy to see why Corteva might want to wall off businesses again.


Corteva Shareholder Reaction

Investors didn’t exactly cheer the news. Corteva stock fell nearly 5% today after the WSJ report. Spinoffs are usually marketed as value-creating, but here the market seems to worry about disruption, added costs, and déjà vu all over again.


Corteva’s Complicated Origins

It’s worth remembering how much reshuffling has already gone into Corteva:

We covered the Corteva debut at the time, noting how unusual (and exhausting) the restructuring was. Now, just six years later, management may be preparing to take it apart once again.


What’s Next for Corteva Spinoff plans?

The WSJ suggests an announcement could come soon. If Corteva does move forward, the separation will be one of the most notable industrial spinoffs of 2026 — not least because it effectively reverses a headline deal of the last decade.

Investors should watch closely:

  • Will management frame this as unlocking growth, or as liability protection?

  • How will they divide debt, cash, and key R&D capabilities?

  • And will the market buy into two separate stories, or punish the complexity all over again?


Disclosure: The author holds no position in Corteva or any stock mentioned.

 

To respond on your own website, enter the URL of your response which should contain a link to this post's permalink URL. Your response will then appear (possibly after moderation) on this page. Want to update or remove your response? Update or delete your post and re-enter your post's URL again. (Find out more about Webmentions.)